Publicacións en colaboración con investigadores/as de Universidade de Lisboa (8)

2023

  1. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

  2. Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study

    Revista Portuguesa de Cardiologia, Vol. 42, Núm. 12, pp. 985-995

2022

  1. Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant

    Revista Espanola de Cardiologia, Vol. 75, Núm. 3, pp. 242-250

2021

  1. Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy

    Journal of Clinical Medicine, Vol. 10, Núm. 7

2020

  1. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  2. Use of sacubitril-valsartan in blood pressure control with left ventricular assist devices

    Journal of Heart and Lung Transplantation

2016

  1. European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology

    European Heart Journal, Vol. 37, Núm. 2, pp. 164-173

  2. Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry

    International Journal of Cardiology, Vol. 219, pp. 331-338